These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
284 related items for PubMed ID: 9836081
1. Altered expression of interferon-gamma and interleukin-4 in inflammatory bowel disease. Camoglio L, Te Velde AA, Tigges AJ, Das PK, Van Deventer SJ. Inflamm Bowel Dis; 1998 Nov; 4(4):285-90. PubMed ID: 9836081 [Abstract] [Full Text] [Related]
2. Profiles of Lamina Propria T Helper Cell Subsets Discriminate Between Ulcerative Colitis and Crohn's Disease. Li J, Ueno A, Fort Gasia M, Luider J, Wang T, Hirota C, Jijon HB, Deane M, Tom M, Chan R, Barkema HW, Beck PL, Kaplan GG, Panaccione R, Qian J, Iacucci M, Gui X, Ghosh S. Inflamm Bowel Dis; 2016 Aug; 22(8):1779-92. PubMed ID: 27243594 [Abstract] [Full Text] [Related]
3. Disparate CD4+ lamina propria (LP) lymphokine secretion profiles in inflammatory bowel disease. Crohn's disease LP cells manifest increased secretion of IFN-gamma, whereas ulcerative colitis LP cells manifest increased secretion of IL-5. Fuss IJ, Neurath M, Boirivant M, Klein JS, de la Motte C, Strong SA, Fiocchi C, Strober W. J Immunol; 1996 Aug 01; 157(3):1261-70. PubMed ID: 8757634 [Abstract] [Full Text] [Related]
4. Patients with inflammatory bowel disease (IBD) reveal increased induction capacity of intracellular interferon-gamma (IFN-gamma) in peripheral CD8+ lymphocytes co-cultured with intestinal epithelial cells. Bisping G, Lügering N, Lütke-Brintrup S, Pauels HG, Schürmann G, Domschke W, Kucharzik T. Clin Exp Immunol; 2001 Jan 01; 123(1):15-22. PubMed ID: 11167992 [Abstract] [Full Text] [Related]
5. The proportion of Th1 cells, which prevail in gut mucosa, is decreased in inflammatory bowel syndrome. Van Damme N, De Keyser F, Demetter P, Baeten D, Mielants H, Verbruggen G, Cuvelier C, Veys EM, De Vos M. Clin Exp Immunol; 2001 Sep 01; 125(3):383-90. PubMed ID: 11531945 [Abstract] [Full Text] [Related]
6. Tissue levels of tumor necrosis factor-alpha correlates with grade of inflammation in untreated ulcerative colitis. Olsen T, Goll R, Cui G, Husebekk A, Vonen B, Birketvedt GS, Florholmen J. Scand J Gastroenterol; 2007 Nov 01; 42(11):1312-20. PubMed ID: 17852866 [Abstract] [Full Text] [Related]
7. Over-expression of interleukin 10 in mucosal T cells of patients with active ulcerative colitis. Melgar S, Yeung MM, Bas A, Forsberg G, Suhr O, Oberg A, Hammarstrom S, Danielsson A, Hammarstrom ML. Clin Exp Immunol; 2003 Oct 01; 134(1):127-37. PubMed ID: 12974765 [Abstract] [Full Text] [Related]
8. Absence of a role for interleukin-13 in inflammatory bowel disease. Biancheri P, Di Sabatino A, Ammoscato F, Facciotti F, Caprioli F, Curciarello R, Hoque SS, Ghanbari A, Joe-Njoku I, Giuffrida P, Rovedatti L, Geginat J, Corazza GR, MacDonald TT. Eur J Immunol; 2014 Feb 01; 44(2):370-85. PubMed ID: 24338958 [Abstract] [Full Text] [Related]
13. Novel CD8+ T-Cell Subsets Demonstrating Plasticity in Patients with Inflammatory Bowel Disease. Tom MR, Li J, Ueno A, Fort Gasia M, Chan R, Hung DY, Chenoo S, Iacucci M, Jijon HB, Kaplan GG, Beck PL, Panaccione R, Barkema HW, Buret AG, Yajnik V, Ghosh S. Inflamm Bowel Dis; 2016 Jul 01; 22(7):1596-608. PubMed ID: 27306067 [Abstract] [Full Text] [Related]
14. Expression, localization, and functional activity of TL1A, a novel Th1-polarizing cytokine in inflammatory bowel disease. Bamias G, Martin C, Marini M, Hoang S, Mishina M, Ross WG, Sachedina MA, Friel CM, Mize J, Bickston SJ, Pizarro TT, Wei P, Cominelli F. J Immunol; 2003 Nov 01; 171(9):4868-74. PubMed ID: 14568967 [Abstract] [Full Text] [Related]
15. Expression of CD45RB functionally distinguishes intestinal T lymphocytes in inflammatory bowel disease. Ten Hove T, The Olle F, Berkhout M, Bruggeman JP, Vyth-Dreese FA, Slors JF, Van Deventer SJ, Te Velde AA. J Leukoc Biol; 2004 Jun 01; 75(6):1010-5. PubMed ID: 15020649 [Abstract] [Full Text] [Related]
16. Type 1 T-helper cell predominance and interleukin-12 expression in the gut of patients with Crohn's disease. Parronchi P, Romagnani P, Annunziato F, Sampognaro S, Becchio A, Giannarini L, Maggi E, Pupilli C, Tonelli F, Romagnani S. Am J Pathol; 1997 Mar 01; 150(3):823-32. PubMed ID: 9060820 [Abstract] [Full Text] [Related]
17. Interleukin-21 enhances T-helper cell type I signaling and interferon-gamma production in Crohn's disease. Monteleone G, Monteleone I, Fina D, Vavassori P, Del Vecchio Blanco G, Caruso R, Tersigni R, Alessandroni L, Biancone L, Naccari GC, MacDonald TT, Pallone F. Gastroenterology; 2005 Mar 01; 128(3):687-94. PubMed ID: 15765404 [Abstract] [Full Text] [Related]
20. Histopathological Features of Inflammatory Bowel Disease are Associated With Different CD4+ T Cell Subsets in Colonic Mucosal Lamina Propria. Gui X, Li J, Ueno A, Iacucci M, Qian J, Ghosh S. J Crohns Colitis; 2018 Nov 28; 12(12):1448-1458. PubMed ID: 30137280 [Abstract] [Full Text] [Related] Page: [Next] [New Search]